New PBS Listings in Australia Will Lower Cost of Kesimpta for Patients

New PBS Listings in Australia Will Lower Cost of Kesimpta for Patients

308430

New PBS Listings in Australia Will Lower Cost of Kesimpta for Patients

People in Australia with multiple sclerosis (MS) and certain other medical conditions will have access to new and expanded medications — including Kesimpta — now listed on the Pharmaceutical Benefits Scheme (PBS). Having these medications on the PBS will lower treatment costs for MS patients and their families, Australian government officials said in a press release. “Without PBS subsidies, many Australians would be thousands of dollars out of pocket,” said Greg Hunt, Australia’s minister for…

You must be logged in to read/download the full post.